We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The TandemHeart PTVA System

By HospiMedica staff writers
Posted on 20 Feb 2007
A short-term extracorporeal circulatory support system provides cardiac assistance through a percutaneous cardiac catheterization procedure in as little as 30 minutes.

The TandemHeart percutaneous transseptal ventricular assist (PTVA) system is a left ventricular assist device (LVAD) designed to be used as a short-term circulatory support system for procedures not requiring complete cardiopulmonary bypass. More...
The system is comprised of three elements: The TandemHeart pump provides the circulating power to pull oxygenated blood from the left atrium and to return it to the systemic arterial circulation; the TandemHeart cannula set connects the pump to the body by way of two percutaneous access points in the patient's groin; and the TandemHeart controller provides operating power to the pump, a controlled flow of lubricant to the pump, and automatic system monitoring and alarms indicating conditions that require attention.

A recently introduced lightweight, space-saving escort controller is also available, which can be mounted at bedside, on an intravenous (IV) pole, or on a table top. It is intended primarily for alternating current (AC) power use, but has enough battery back-up power for an hour of operation. The TandemHeart PTVA system is a product of CardiacAssist (Pittsburgh, PA, USA), and has been approved by the U.S. Food and Drug Administration (FDA) for short-term use for up to six hours.

"The clinical experience with TandemHeart is now very substantial,” said CardiacAssist CEO Michael Garippa. "Design improvements have made the system more portable and capable of delivering up to 5 l/min of critical blood flow. We're very excited about the prospects for 2007 as our technology continues to be adopted by hospitals and institutions in the United States and around the world.”


Related Links:
CardiacAssist

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Wound Irrigation Solution
Prontosan®
New
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.